| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |